P G Wardle

No ORCID on file · 12 papers in corpus · active 1983-2000

Study types

  • article 8
  • case-report 1
  • letter 1
  • other 1
  • review 1

Condition tags

  • endometriosis 11
  • infertility 6
  • dysmenorrhea 1
  • dyspareunia 1
article 2000
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/j.8755-8920.2000.430201.x

PROBLEM: To measure and compare concentrations of inhibin A, inhibin B, activin A and oestradiol in the follicular fluid of women with endometriosis, tubal damage and unexplained infertility with oocyte quality and fertilising capacity. Als…

article 1998
Fertility and Sterility ·doi:10.1016/s0015-0282(98)00113-7
article 1997
Journal of assisted reproduction and genetics ·doi:10.1023/a:1022568331845
other 1996
Fertility and Sterility ·doi:10.1016/s0015-0282(16)58058-3
article 1996
Human Reproduction ·doi:10.1093/humrep/11.3.647

Evidence of pituitary-ovarian dysfunction in unexplained and endometriosis-associated infertility has been reported previously. Hormone-suppressive therapy is often used in an attempt to improve fertility, although benefits have not been pr…

article 1996
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem.81.1.8550788

To examine the cause of altered follicular fluid steroid levels and lower in vitro fertilization rate observed in infertile women with minor endometriosis, we have compared the production of estradiol (aromatase activity) and progesterone o…

article 1995
Human Reproduction ·doi:10.1093/oxfordjournals.humrep.a135876

This study examines circulating and follicular hormone concentrations and fertilization of oocytes in cycles totally unperturbed by exogenous gonadotrophins in 10 women (25 cycles) with untreated minimal-mild endometriosis and nine women (2…

article 1995
British journal of obstetrics and gynaecology ·doi:10.1111/j.1471-0528.1995.tb09160.x

In a large, double-blind, multicentre study, 269 patients with confirmed endometriosis were randomly allocated to receive either danazol (200 mg twice daily; n = 137) or gestrinone (2.5 mg twice weekly; n = 132) for 6 months. The two groups…

review 1993
Bailliere's clinical obstetrics and gynaecology ·doi:10.1016/s0950-3552(05)80457-2
letter 1986
Lancet (London, England) ·doi:10.1016/s0140-6736(86)90815-9
article 1985
Lancet (London, England) ·doi:10.1016/s0140-6736(85)90289-2
case-report 1983
British medical journal (Clinical research ed.) ·doi:10.1136/bmj.287.6397.946